Literature DB >> 11304477

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.

S R Thomas1, S B Leichtweis, K Pettersson, K D Croft, T A Mori, A J Brown, R Stocker.   

Abstract

Intimal oxidation of LDL is considered an important early event in atherogenesis, and certain antioxidants are antiatherogenic. Dietary coenrichment with vitamin E (VitE) plus ubiquinone-10 (CoQ(10), which is reduced during intestinal uptake to the antioxidant ubiquinol-10, CoQ(10)H(2)) protects, whereas enrichment with VitE alone can increase oxidizability of LDL lipid against ex vivo oxidation. In the present study, we tested whether VitE plus CoQ(10) cosupplementation is more antiatherogenic than either antioxidant alone, by use of apolipoprotein E-deficient (apoE-/-) mice fed a high-fat diet without (control) or with 0.2% (wt/wt) VitE, 0.5% CoQ(10), or 0.2% VitE plus 0.5% CoQ(10) (VitE+CoQ(10)) for 24 weeks. None of the supplements affected plasma cholesterol concentrations, whereas in the VitE and CoQ(10) groups, plasma level of the respective supplement increased. Compared with control, plasma from CoQ(10) or VitE+CoQ(10) but not VitE-supplemented animals was more resistant to ex vivo lipid peroxidation induced by peroxyl radicals. VitE supplementation increased VitE levels in aorta, heart, brain, and skeletal muscle, whereas CoQ(10) supplementation increased CoQ(10) only in plasma and aorta and lowered tissue VITE: All treatments significantly lowered aortic cholesterol compared with control, but only VitE+CoQ(10) supplementation significantly decreased tissue lipid hydroperoxides when expressed per parent lipid. In contrast, none of the treatments affected aortic ratios of 7-ketocholesterol to cholesterol. Compared with controls, VitE+CoQ(10) supplementation decreased atherosclerosis at the aortic root and arch and descending thoracic aorta to an extent that increased with increasing distance from the aortic root. CoQ(10) significantly inhibited atherosclerosis at aortic root and arch, whereas VitE decreased disease at aortic root only. Thus, in apoE-/- mice, VitE+CoQ(10) supplements are more antiatherogenic than CoQ(10) or VitE supplements alone and disease inhibition is associated with a decrease in aortic lipid hydroperoxides but not 7-ketocholesterol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304477     DOI: 10.1161/01.atv.21.4.585

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

Review 1.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77).

Authors:  Job C Tharappel; Hans-Joachim Lehmler; Cidambi Srinivasan; Larry W Robertson; Brett T Spear; Howard P Glauert
Journal:  Food Chem Toxicol       Date:  2008-08-30       Impact factor: 6.023

Review 3.  F2-isoprostanes as an indicator and risk factor for coronary heart disease.

Authors:  Sean S Davies; L Jackson Roberts
Journal:  Free Radic Biol Med       Date:  2010-11-30       Impact factor: 7.376

4.  Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.

Authors:  Xiaoxiao Yang; Hui Yao; Yuanli Chen; Lei Sun; Yan Li; Xingzhe Ma; Shengzhong Duan; Xiaoju Li; Rong Xiang; Jihong Han; Yajun Duan
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

5.  Evaluation of antioxidant systems in pituitary-adrenal axis diseases.

Authors:  A Mancini; E Leone; A Silvestrini; R Festa; V Di Donna; L De Marinis; A Pontecorvi; G P Littarru; E Meucci
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

6.  Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice.

Authors:  Michelle M Averill; Brian J Bennett; Marcello Rattazzi; Rebecca M Rodmyre; Elizabeth A Kirk; Stephen M Schwartz; Michael E Rosenfeld
Journal:  Atherosclerosis       Date:  2008-07-01       Impact factor: 5.162

7.  Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons.

Authors:  Xing Li Wang; David L Rainwater; Michael C Mahaney; Roland Stocker
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

Review 8.  Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?

Authors:  Jay W Heinecke
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

9.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia.

Authors:  Irini Manoli; Justin R Sysol; Lingli Li; Pascal Houillier; Caterina Garone; Cindy Wang; Patricia M Zerfas; Kristina Cusmano-Ozog; Sarah Young; Niraj S Trivedi; Jun Cheng; Jennifer L Sloan; Randy J Chandler; Mones Abu-Asab; Maria Tsokos; Abdel G Elkahloun; Seymour Rosen; Gregory M Enns; Gerard T Berry; Victoria Hoffmann; Salvatore DiMauro; Jurgen Schnermann; Charles P Venditti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.